Option Care Health, Inc. announced preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2024. For Q4 2024, the company expects net revenue between $1.34 billion and $1.36 billion, adjusted EBITDA between $115 million and $120 million, and adjusted EPS between $0.43 and $0.45. Full-year 2024 expectations include net revenue of $4.99 billion to $5.01 billion, adjusted EBITDA of $440 million to $445 million, and adjusted EPS of $1.55 to $1.57.
The company also provided preliminary financial expectations for the full year 2025, projecting revenue between $5.4 billion and $5.6 billion, adjusted EBITDA between $455 million and $470 million, and adjusted EPS between $1.61 and $1.70. This guidance incorporates an anticipated negative gross profit impact of approximately $60 million to $70 million related to STELARA pricing adjustments.
In a significant capital deployment move, Option Care Health completed the remaining $90 million of share repurchases under its prior program in the fourth quarter of 2024. On January 10, 2025, the company's Board of Directors approved a new $500 million stock repurchase program, demonstrating a continued commitment to enhancing shareholder value.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.